US Bancorp
TRIB

US Bancorp’s Trinity Biotech TRIB Stock Holding History

US Bancorp’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-194
Closed -$417 – 4100
2023
Q4 		$417 Hold
194
– – ﹤0.01% 3863
2023
Q3 		$715 Hold
194
– – ﹤0.01% 3817
2023
Q2 		$924 Hold
194
– – ﹤0.01% 3815
2023
Q1 		$914 Hold
194
– – ﹤0.01% 3891
2022
Q4 		$962 Hold
194
– – ﹤0.01% 3930
2022
Q3 		$1K Hold
194
– – ﹤0.01% 4011
2022
Q2 		$1K Sell
194
-13
-6% -$79 ﹤0.01% 4009
2022
Q1 		$1K Hold
207
– – ﹤0.01% 4002
2021
Q4 		$1K Hold
207
– – ﹤0.01% 4034
2021
Q3 		$2K Sell
207
-17
-8% -$199 ﹤0.01% 3922
2021
Q2 		$3K Hold
224
– – ﹤0.01% 3763
2021
Q1 		$4K Hold
224
– – ﹤0.01% 3566
2020
Q4 		$4K Sell
224
-19
-8% -$314 ﹤0.01% 3462
2020
Q3 		$2K Hold
243
– – ﹤0.01% 3524
2020
Q2 		$3K Sell
243
-1
-0.4% -$8 ﹤0.01% 3451
2020
Q1 		$1K Hold
244
– – ﹤0.01% 3610
2019
Q4 		$1K Hold
244
– – ﹤0.01% 3594
2019
Q3 		$1K Sell
244
-177
-42% -$1.54K ﹤0.01% 3520
2019
Q2 		$3K Sell
421
-852
-67% -$10.1K ﹤0.01% 3404
2019
Q1 		$18K Sell
1,273
-793
-38% -$10.9K ﹤0.01% 2901
2018
Q4 		$24K Hold
2,066
– – ﹤0.01% 2746
2018
Q3 		$41K Sell
2,066
-313
-13% -$6.8K ﹤0.01% 2657
2018
Q2 		$59K Sell
2,379
-1,800
-43% -$43.3K ﹤0.01% 2496
2018
Q1 		$108K Sell
4,179
-3,243
-44% -$88.5K ﹤0.01% 2195
2017
Q4 		$189K Sell
7,422
-6,472
-47% -$167K ﹤0.01% 1917
2017
Q3 		$390K Sell
13,894
-9,102
-40% -$254K ﹤0.01% 1535
2017
Q2 		$690K Sell
22,996
-47,441
-67% -$1.34M ﹤0.01% 1252
2017
Q1 		$2.1M Buy
70,437
+2,092
+3% +$65.4K 0.01% 761
2016
Q4 		$2.37M Buy
68,345
+170
+0.2% +$5.86K 0.01% 695
2016
Q3 		$4.51M Sell
68,175
-1,839
-3% -$114K 0.02% 486
2016
Q2 		$3.97M Buy
70,014
+4,971
+8% +$280K 0.02% 498
2016
Q1 		$3.79M Buy
65,043
+17,278
+36% +$917K 0.01% 503
2015
Q4 		$2.81M Buy
47,765
+24,243
+103% +$1.43M 0.01% 600
2015
Q3 		$1.34M Buy
23,522
+9,255
+65% +$745K 0.01% 824
2015
Q2 		$1.29M Buy
14,267
+3,674
+35% +$318K 0.01% 893
2015
Q1 		$1.02M Buy
10,593
+1,519
+17% +$140K ﹤0.01% 1007
2014
Q4 		$794K Sell
9,074
-2,648
-23% -$228K ﹤0.01% 1107
2014
Q3 		$1.07M Sell
11,722
-5,293
-31% -$573K ﹤0.01% 961
2014
Q2 		$1.96M Buy
17,015
+618
+4% +$73.2K 0.01% 716
2014
Q1 		$1.99M Buy
16,397
+4,824
+42% +$632K 0.01% 695
2013
Q4 		$1.46M Buy
11,573
+4,157
+56% +$499K 0.01% 769
2013
Q3 		$807K Buy
7,416
+3,519
+90% +$343K ﹤0.01% 988
2013
Q2 		$329K Buy
+3,897
New +$323K ﹤0.01% 1391

Other funds holding TRIB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

US Bancorp's TRIB Position: Q1 2024 in Review

US Bancorp sold out of Trinity Biotech (TRIB) in Q1 2024, closing a stake of 194 shares — an estimated $417 sold.

US Bancorp first reported a position in TRIB in Q2 2013 and held it in 43 quarters. The position peaked at $4.51M in Q3 2016. 19 funds tracked by Wall St. Rank hold TRIB as of Q1 2024.

  • US Bancorp reported no remaining Trinity Biotech position as of Q1 2024 after selling out during the quarter.
  • US Bancorp sold 194 Trinity Biotech shares in Q1 2024, an estimated $417.
  • US Bancorp first reported a position in Trinity Biotech in Q2 2013 and held it in 43 quarters.
  • US Bancorp's Trinity Biotech position peaked at $4.51M in Q3 2016.
  • 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2024.

Based on US Bancorp's 13F filing for Q1 2024, filed 8 May 2024.